Intelligent Medicine Sponsor LLC - 08 Feb 2023 Form 4 Insider Report for Intelligent Medicine Acquisition Corp.

Role: 10%+ Owner
Signature: Intelligent Medicine Sponsor LLC By: /s/ Gregory C. Simon Managing Member of Intelligent Medicine Sponsor LLC
Issuer symbol: N/A
Transactions as of: 08 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 10 Feb 2023, 15:20:27 UTC
Previous filing: 04 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IQMD	Class B Common Stock	Gift	$0	-200,000	-4.1%	$0.000000	4,700,000	08 Feb 2023	Class A Common Stock	200,000	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 8, 2023, the reporting person contributed 200,000 shares of Class B Common Stock to the Issuer's IPO Trust Account, for the benefit of the public shares that were not redeemed by the public shareholders in connection with the special meeting of shareholders held on February 8, 2023.
F2	As described in the Issuer's Registration Statement on Form S-1 (File No. 333-260205) (the "Registration Statement") under the heading "Description of Securities - Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.

Content

On February 8, 2023, the reporting person contributed 200,000 shares of Class B Common Stock to the Issuer's IPO Trust Account, for the benefit of the public shares that were not redeemed by the public shareholders in connection with the special meeting of shareholders held on February 8, 2023.

As described in the Issuer's Registration Statement on Form S-1 (File No. 333-260205) (the "Registration Statement") under the heading "Description of Securities - Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.